Galena Biopharma - Stock Price History | SLS

Historical daily share price chart and data for Galena Biopharma since 2021 adjusted for splits. The latest closing stock price for Galena Biopharma as of September 24, 2021 is 10.02.
  • The all-time high Galena Biopharma stock closing price was 408408.41 on March 13, 2008.
  • The Galena Biopharma 52-week high stock price is 19.38, which is 93.4% above the current share price.
  • The Galena Biopharma 52-week low stock price is 2.33, which is 76.7% below the current share price.
  • The average Galena Biopharma stock price for the last 52 weeks is 7.70.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Galena Biopharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 3.0119 4.0800 17.6600 1.5300 5.8100 35.12%
2019 28.9461 70.5000 83.0000 3.7900 4.3000 -93.01%
2018 176.0097 335.2250 448.5000 40.9100 61.5000 -84.37%
2017 915.2806 2972.9730 3108.1081 393.3934 393.3934 -86.49%
2016 23485.1756 43243.2432 68168.1682 2912.9129 2912.9129 -93.40%
2015 48333.4525 46846.8468 67267.2673 39039.0390 44144.1441 -2.65%
2014 84089.3036 152552.5526 224624.6246 44744.7447 45345.3453 -69.56%
2013 70637.7807 47747.7477 148948.9489 47747.7477 148948.9489 224.18%
2012 46541.4414 14114.1141 83183.1832 13213.2132 45945.9459 226.23%
2011 34005.1361 77777.7778 77777.7778 11144.1441 14084.0841 -81.82%
2010 108859.4190 123123.1231 243543.5435 52552.5526 77477.4775 -43.67%
2009 116789.8375 180180.1802 221921.9219 47447.4474 137537.5375 -20.35%
2008 240536.3510 315615.6156 408408.4084 165465.4655 172672.6727 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.163B $0.002B
SELLAS Life Sciences Group is a development-stage biopharmaceutical company. It focused on novel cancer immunotherapeutics for cancer indications. The company's product candidate, galinpepimut-S, is licensed from Memorial Sloan Kettering Cancer Center and targets the Wilms Tumor 1 protein, which is present in an array of tumor types. SELLAS Life Sciences Group Inc., formerly known as Galena Biopharma Inc., is based in NEW YORK, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71